Arcus Biosciences, Inc. — Director's Dealing 2024

Dec 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2024-12-15

Reporting Person: Nuyten Dimitry SA (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-15	Common Stock	F	7856	$16.08	Disposed	87518	Direct

Footnotes

F1: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.